MA (EU) number
(Invented) 
name
Strength
Pharmaceutical 
form
Route of 
administration
Immediate 
Packaging
Content 
(concentration)
Pack size
EU/1/15/1007/001
Gardasil 9
EU/1/15/1007/002
Gardasil 9
EU/1/15/1007/003
Gardasil 9
EU/1/15/1007/004
Gardasil 9
--1
--1
--1
--1
--1 1 dose (0.5 ml) contains approximately:
Suspension for 
injection
Suspension for 
injection
Suspension for 
injection
Suspension for 
injection
Intramuscular 
use
Intramuscular 
use
Intramuscular 
use
Intramuscular 
use
vial (glass)
pre-filled syringe
(glass)
pre-filled syringe
(glass)
pre-filled syringe
(glass)
0.5 ml
0.5 ml
0.5 ml
0.5 ml
1 vial
1 syringe + 2 
needles
10 syringes + 20
needles
10 syringes
Human Papillomavirus1 Type 6 L1 protein2,3 30 micrograms
Human Papillomavirus1 Type 11 L1 protein2,3 40 micrograms
Human Papillomavirus1 Type 16 L1 protein2,3 60 micrograms
Human Papillomavirus1 Type 18 L1 protein2,3 40 micrograms
Human Papillomavirus1 Type 31 L1 protein2,3 20 micrograms
Human Papillomavirus1 Type 33 L1 protein2,3 20 micrograms
Human Papillomavirus1 Type 45 L1 protein2,3 20 micrograms
Human Papillomavirus1 Type 52 L1 protein2,3 20 micrograms
Human Papillomavirus1 Type 58 L1 protein2,3 20 micrograms
¹ Human Papillomavirus = HPV
² L1 protein in the form of virus-like particles produced in yeast cells (Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA 
technology
³ adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (0.5 milligrams Al)
1
 
